Latest Research News

Yale researchers Dibyadeep Datta, PhD, assistant professor of psychiatry, and Amy Arnsten, PhD, Albert E. Kent Professor of Neuroscience and professor of psychology, led a study that probed a blood biomarker for early-stage Alzheimer’s disease. The findings were published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

A new study by VA Connecticut Healthcare System and Yale School of Medicine researchers assesses how the most up-to-date genetic and psychosocial predictors of opioid use disorder compare and combine when predicting the risk of becoming dependent on opioids.

Patients who use cannabis while being medically treated for opioid use disorder are not at greater risk of returning to non-medical opioid use, a new meta-analysis by Yale researchers reveals. Joao P. De Aquino, MD, assistant professor of psychiatry, and Julio Nunes, MD, a second-year psychiatry resident, are co-authors.

The Department of Veterans Affairs’ Veterans Benefits Administration denied a higher percentage of service-connection disability benefits claims by people who suffered from posttraumatic stress disorder related to military sexual trauma than for people who submitted PTSD combat-related claims, according to a new study by Yale researchers, including lead author Aliya Webermann, PhD, and senior author Anne Black, PhD.

Carlos Grilo, PhD, professor of psychiatry and of psychology; Janet Lydecker, PhD, assistant professor of psychiatry; and Ralitza Gueorguieva, PhD, senior research scientist in biostatistics, are co-authors of a paper in Cambridge University Press that tests the efficacy of naltrexone/bupropion maintenance treatment among responders to acute treatments for binge eating disorder.

A review in Molecular Psychiatry concluded ketamine-assisted electroconvulsive therapy is tolerable and may be efficacious in improving depressive symptoms, but a relative adverse impact on cognition may be an important clinical consideration. Greg Rhee, PhD, assistant professor adjunct of psychiatry, was the lead author.

On September 12, Women's Health Research at Yale held its 25th anniversary celebration honoring decades of discovery and innovation.

A commitment to the community starts locally, builds regionally, then nationally and internationally.

Julio Nunes, MD, second-year resident, and Joao P. De Aquino, MD, assistant professor of psychiatry, are first and senior authors, respectively, of a paper in American Journal on Addictions that examines the impact of childhood trauma on delta-9-tetrahydrocannabinol effects.